Breaching the Blood-Brain Barrier

Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, JON OLAV EIKENESThe key to breaching the last great biochemical barricade in the body—the blood-brain barrier, a tightly packed layer of cells critical for keeping pathogens and toxins out of the central nervous system—was sound. A team at Sunnybrook Health Sciences Centre in Toronto injected a chemotherapy drug along with tiny gas bubbles into the bloodstream of a patient, then trained ultrasound waves on her skull, causing the bubbles to expand and contract at a rate of about 200,000 times a second and punch temporary holes in the endothelial cell layer of the blood-brain barrier, Focused Ultrasound Foundation announced this week (November 9).

“Opening the barrier is really of huge importance. It is probably the major limitation for innovative drug development for neurosciences,” Bart De Strooper, codirector of the Leuven Institute for Neuroscience and Disease in Belgium, told New Scientist.

The patient, 56-year-old Bonny Hall, has suffered a brain tumor for the past eight years. While it had been kept under control with various medications, earlier this year it started to grow. The experimental treatment allowed the chemotherapy agent to be delivered directly to her tumor. An MRI scan confirmed that the technique worked in opening the blood-brain barrier, and the researchers will now examine Hall’s tumor, which was removed surgically the day after the therapy, to determine just how much of the drug penetrated. Hall told BBC ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies